Measles Outbreak Cases Cross 100 Mark In US, Australia Sees Sudden Surge Of The Infectious Disease

Updated Feb 23, 2025 | 11:46 AM IST

SummaryMeasles continues to create havoc with over 100 people infected in US. New health guidelines and advisories are being issued to ensure people remain safe and vigilant.
(Credit-Canva)

(Credit-Canva)

The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.

Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.

Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.

Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.

Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.

What Are The Symptoms Measles?

Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.

Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.

Why It Is Important To Get Vaccinated?

According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.

Who Should Get Vaccinated?

Kids Need Two Shots

All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.

College Students Need to Be Protected

Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.

Adults Need at Least One Shot

Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.

Travelers Need to Be Extra Careful

Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.

Healthcare Workers Must Be Immune

People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.

Women Thinking About Having Babies

Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.

End of Article

Tini Younger Reveals Losing Baby Girl To Placental Abruption—What Is This Condition?

Updated Nov 27, 2025 | 05:37 PM IST

SummaryTikTok chef Tini Younger has shared heartbreaking news after losing one of her twin baby girls due to a placental abruption. While her surviving twin is healthy, Younger’s post sheds light on this rare and serious pregnancy complication, its symptoms, and the importance of timely medical care.
tini younger placental abruption

Credits: Tini Younger Instagram/Canva

Tineke “Tini” Younger shared some devastating news on Wednesday, November 26. The 24-year-old TikTok chef and Next Level Chef alum revealed that one of her twin daughters with husband Antoine Wright Jr. had tragically passed away.

Tini Younger Announces Loss Of Her Baby Girl

Younger said that their daughter Arya, known as Baby A, died just before reaching 36 weeks of pregnancy. In a heartfelt Instagram post, she wrote, "This isn’t the post I ever imagined I would share once the twins arrived. Unfortunately, earlier this week we lost our sweet girl Arya." She explained that despite being so close to full term, she experienced a placental abruption that caused the loss of her baby.

The surviving twin was born safely and is reportedly breathing independently, according to Younger. She has not shared the name of the second daughter.

What Is Placental Abruption?

Placental abruption, medically referred to as abruptio placentae, is an uncommon yet serious complication during pregnancy. The placenta develops inside the uterus and attaches to its wall, providing essential oxygen and nutrients to the growing baby.

Placental abruption happens when the placenta partially or fully detaches from the uterine wall before delivery. This separation can restrict or completely cut off the baby’s supply of oxygen and nutrients while also causing significant bleeding in the mother. According to the Mayo Clinic, the placenta is an organ that forms in the uterus during pregnancy. When placental abruption occurs, the placenta separates from the inner wall of the uterus before birth, which can deprive the baby of vital oxygen and nutrients and lead to heavy maternal bleeding. In some situations, early delivery may be required to protect both mother and child.

Placental abruption often appears suddenly, and if it is not treated promptly, it can pose serious risks to both the mother and the baby.

Symptoms Of Placental Abruption

Placental abruption is most likely to develop in the last trimester of pregnancy, particularly in the final few weeks before delivery. Signs and symptoms may include:

  • Vaginal bleeding, though sometimes there may be none
  • Abdominal pain
  • Back pain
  • Uterine tenderness or rigidity
  • Uterine contractions, often coming one immediately after another

Abdominal and back pain often start suddenly. The amount of vaginal bleeding can vary widely and does not necessarily reflect how much of the placenta has detached from the uterus. Blood may become trapped inside the uterus, so even in severe cases of placental abruption, there might not be any visible bleeding.

In some instances, placental abruption develops gradually, referred to as chronic abruption. This may cause light, intermittent vaginal bleeding. Babies might grow more slowly than expected, and there could be other complications, such as low amniotic fluid or additional issues affecting fetal development.

What Causes Placental Abruption?

The precise cause of placental abruption is often unknown. Healthcare professionals can, however, identify certain factors that increase the risk. For example, abdominal trauma, including falls or accidents, can raise the chances of experiencing a placental abruption.

If you notice any of these symptoms, it is strongly recommended to seek medical care immediately to ensure both your safety and your baby’s.

End of Article

Victorian Skin Disease Linked To Intense Itching Surges In The UK: Symptoms To Look For

Updated Nov 27, 2025 | 08:00 PM IST

SummaryA college in the UK has reported an outbreak of a Victorian-era skin condition that has been appearing more often across the UK. Recent rises in cases across London and northern England have encouraged health experts to urge families and students to watch for symptoms.
victorian skin disease scabies uk

Credits: Canva

A college in Devon, UK, has issued a public health notice after confirming an outbreak of a disease often tied to the Victorian era. It is not something most people come across today, yet reports show that this old skin condition is appearing more often in modern settings. Although it is usually linked with unclean surroundings, anyone can get it, no matter how carefully they maintain personal or household hygiene.

One woman described her nine-month struggle with the illness. At first she dismissed it as an allergy but soon noticed her son had developed a similar rash and persistent itching. Amanda Rushton from Accrington in Lancashire told The Daily Mail she felt as if her “skin was crawling” once she learnt what she was dealing with.

What Are Victorian Diseases?

In the UK, 'Victorian diseases' refers to illnesses that were widespread during the 19th century and are now returning due to factors such as poverty and limited access to care. These include tuberculosis, cholera, scarlet fever, and scurvy. Many of these conditions are tied to poor sanitation or nutrition.

Tuberculosis was once known as “consumption,” and infections like scabies and measles have also been seen more frequently in recent years, according to the official UK government website.

Victorian Disease Warning In UK

Specialists have raised concerns that more parents choosing to skip routine childhood vaccinations are placing infants and other high-risk groups in danger. The illness circulating at the Devon college is scabies.

“We have been notified of seven confirmed cases of scabies amongst our student community,” read an email from South Devon College in Paignton, reported by DevonLive. “These cases have been diagnosed by a health professional.”

What Is Scabies?

Scabies is a very itchy skin infestation caused by tiny mites known as Sarcoptes scabiei. These mites burrow into the upper layers of the skin to feed and lay eggs. The body reacts to this by producing a rash of small bumps and intense itching, which often becomes worse at night. The condition spreads easily through close and prolonged skin contact and can also pass indirectly through contaminated clothing, bedding, or towels, according to Mayo Clinic.

Scabies tends to spread faster in crowded environments or shared living spaces such as child-care centres or nursing homes. Pets cannot give scabies to humans, as animals carry a different type of mite that causes mange, as noted by the Cleveland Clinic.

Scabies Symptoms To Look Out For

The most common sign of scabies is a fierce, unrelenting itch that worsens at night, along with a rash. You may also notice thin, raised, curved lines called burrows and small bumps or blisters. These usually appear in warm or folded areas of the skin, such as between the fingers and toes. Continuous scratching can break the skin, causing sores or scabs.

Scabies Common Symptoms

Intense itching: This is the leading symptom and often disturbs sleep because of how severe it becomes at night.

Rash: The rash may look like small bumps, pimples, or tiny blisters.

Burrows: These appear as narrow, winding lines created by female mites as they tunnel through the skin to lay eggs.

Sores: Scratching can result in broken skin and crusts.

Common Locations For The Rash

  • Between the fingers and toes
  • Wrists, elbows, and knees
  • The genital region
  • Around the breasts or nipples
  • The waistline and belly button
  • Under the fingernails or watch straps
  • In babies and young children, the rash may spread more widely and can show up on the face, head, and neck.

Scabies Cases Rising In The UK

London saw a noticeable increase in scabies toward the end of last year, and similar spikes were reported across northern England, especially in care facilities, nursing homes, and university housing. With cases climbing, doctors are urging people to stay alert to common signs.

Dr Donald Grant, GP and Senior Clinical Advisor at The Independent Pharmacy, explained to Women’s Health last month that although there is no single clear cause for the rise, several factors may be contributing. He told The Independent that this period of the year allows scabies to spread more easily, with children returning to school and students moving into shared accommodation, both of which involve frequent close contact.

He added that scabies is often confused with other skin problems, especially eczema or allergic reactions.

Doctors note that the condition is usually not dangerous, but it must be treated because it passes from person to person so easily. Symptoms may take up to eight weeks to appear after the mites enter the skin. Anyone who suspects they might have scabies should speak to a pharmacist. Every person in the household needs treatment at the same time, even if they do not have visible symptoms.

End of Article

Brazil Becomes The First Country To Authorise A Single-Dose Dengue Vaccine: All You Need To Know

Updated Nov 27, 2025 | 12:01 PM IST

SummaryBrazil has approved the world’s first single-dose dengue vaccine, Butantan-DV, for people aged 12 to 59. The live attenuated virus shot offers around 75% protection against symptomatic dengue, a disease that reached record global levels in 2024. Keep reading for more details.
brazil single dose dengue vaccine

Credits: Canva

Brazilian authorities on Wednesday approved the world’s first single-dose dengue vaccine, describing it as a “historic” step amid a global surge in cases fueled by rising temperatures. Dengue, which causes severe flu-like symptoms, extreme fatigue, and body aches, hit record global levels in 2024, with scientists linking its rapid spread to climate change. Brazil’s health regulatory body ANVISA cleared the use of Butantan-DV, created by the Butantan Institute in São Paulo, for individuals aged 12 to 59.

Until now, the only dengue vaccine available globally was TAK-003, which requires two doses spaced three months apart, according to the World Health Organization (WHO). Here’s everything currently known about this single-dose vaccine.

Also Read: GRAP 3 Restrictions Revoked In Delhi-NCR: What Residents Can Use Again And What Stays Restricted

Dengue Single Dose Vaccine Approved In Brazil

On Wednesday, November 26, Anvisa approved the world’s first single-dose dengue vaccine. The announcement followed the signing of a term considered the final step in registering the vaccine, produced entirely at a national laboratory, during a press conference, as reported by CNN Brazil. The development of Butantan-DV is the result of collaboration between Brazil’s Ministry of Health, the Butantan Institute, and the Chinese lab Wu Xi.

Butantan-DV: All You Need To Know About The Single Dose Dengue Vaccine

Anvisa stated that the new vaccine uses live attenuated virus technology and is currently approved for people aged 12 to 59—a range that could expand if new studies support it. The Ministry of Health will determine the official vaccination start date and the target age group. The registration request for the vaccine was submitted by the Butantan Institute in January 2025. Anvisa fast-tracked its evaluation, forming a technical panel that included external experts to review the process.

What Is A Live Attenuated Virus?

A live attenuated virus is a weakened form of a virus used in vaccines to trigger a strong and lasting immune response without causing the full-blown disease. These viruses are developed in a lab, often through repeated culturing, so they can replicate in the body but only in a limited way. By closely mimicking a natural infection, they prompt the immune system to respond similarly to how it would during a real infection, according to the U.S. Department of Health and Human Services.

Also Read: CDC To Appoint Vaccine-Skeptic Surgeon Ralph Abraham As Deputy Director

How Effective Is This Single Dose Dengue Vaccine?

CNN Brazil reported that the Ministry of Health found the vaccine to have an overall efficacy of 74.7% against symptomatic dengue for people aged 12 to 59. This means that nearly three out of four people were protected from the disease. Protection was similar for those who had previously had dengue and those who were never exposed to the virus.

In 2024, over 14 million dengue cases were reported globally, marking a record year, according to ScienceDirect and WHO. The death toll reached more than 9,500. While the Americas reported the highest number of cases, dengue continues to affect more than 100 countries worldwide.

Dengue, often called “breakbone fever” because of its intense symptoms, can in severe cases lead to hemorrhagic fever and even death. The disease spreads through infected Aedes mosquitoes, which are now appearing in areas beyond their traditional habitats, resulting in dengue cases in parts of Europe and the United States where it was previously uncommon.

End of Article